This compound is a protected dipeptide consisting of valine and citrulline, with a fluorenylmethoxycarbonyl (Fmoc) protecting group. It is used as an intermediate in peptide synthesis, particularly in the preparation of conjugates for research applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 159858-21-6
Fmoc-Val-Lys(Boc)-OH
research compound
Fmoc-Val-Cit-PAB
research compound
N-Boc-N'-Fmoc-L-ornithine
pharmaceutical intermediate
(23S,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
pharmaceutical intermediate
Boc-His(Trt)-Aib-OH
pharmaceutical intermediate
(2S)-4-[[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid
pharmaceutical intermediate
High School DxD
pharmaceutical intermediate
(3R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
pharmaceutical intermediate
(2S)-5-(carbamoylamino)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoyl]amino]pentanoic acid
ZJLNQOIFTYLCHC-VXKWHMMOSA-N
CC(C)[C@@H](C(=O)N[C@@H](CCCNC(=O)N)C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13